Literature DB >> 27943662

Development of Polymer Microcapsules Functionalized with Fucoidan to Target P-Selectin Overexpressed in Cardiovascular Diseases.

Bo Li1,2, Maya Juenet1,2, Rachida Aid-Launais1,2, Murielle Maire1,2, Véronique Ollivier1,2, Didier Letourneur1,2, Cédric Chauvierre1,2.   

Abstract

New tools for molecular imaging and targeted therapy for cardiovascular diseases are still required. Herein, biodegradable microcapsules (MCs) made of polycyanoacrylate and polysaccharide and functionalized with fucoidan (Fuco-MCs) are designed as new carriers to target arterial thrombi overexpressing P-selectin. Physicochemical characterizations demonstrated that microcapsules have a core-shell structure and that fucoidan is present onto the surface of Fuco-MCs. Furthermore, their sizes range from 2 to 6 µm and they are stable on storage over 30 d at 4 °C. Flow cytometry experiments evidenced the binding of Fuco-MCs for human activated platelets as compared to MCs (mean fluorescence intensity: 12 008 vs. 9, p < 0.001) and its absence for nonactivated platelets (432). An in vitro flow adhesion assay showed high specific binding efficiency of Fuco-MCs to P-selectin and to activated platelet aggregates under arterial shear stress conditions. Moreover, both types of microcapsules reveal excellent compatibility with 3T3 cells in cytotoxicity assay. One hour after intravenous injection of microcapsules, histological analysis revealed that Fuco-MCs are localized in the rat abdominal aortic aneurysm thrombotic wall and that the binding in the healthy aorta is low. In conclusion, these microcapsules appear as promising carriers for targeting of tissues characterized by P-selectin overexpression and for their molecular imaging or treatment.
© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  P-selectin; fucoidan; molecular targeting; polymer microcapsules; thrombosis

Mesh:

Substances:

Year:  2016        PMID: 27943662     DOI: 10.1002/adhm.201601200

Source DB:  PubMed          Journal:  Adv Healthc Mater        ISSN: 2192-2640            Impact factor:   9.933


  12 in total

Review 1.  From design to the clinic: practical guidelines for translating cardiovascular nanomedicine.

Authors:  Iwona Cicha; Cédric Chauvierre; Isabelle Texier; Claudia Cabella; Josbert M Metselaar; János Szebeni; László Dézsi; Christoph Alexiou; François Rouzet; Gert Storm; Erik Stroes; Donald Bruce; Neil MacRitchie; Pasquale Maffia; Didier Letourneur
Journal:  Cardiovasc Res       Date:  2018-11-01       Impact factor: 10.787

2.  Targeting P-Selectin Adhesion Molecule in Molecular Imaging: P-Selectin Expression as a Valuable Imaging Biomarker of Inflammation in Cardiovascular Disease.

Authors:  Lydia A Perkins; Carolyn J Anderson; Enrico M Novelli
Journal:  J Nucl Med       Date:  2019-10-10       Impact factor: 10.057

3.  Low molecular weight fucoidan attenuates experimental abdominal aortic aneurysm through interfering the leukocyte-endothelial cells interaction.

Authors:  Min Zhou; Yong Ding; Liang Cai; Yonggang Wang; Changpo Lin; Zhenyu Shi
Journal:  Mol Med Rep       Date:  2018-03-16       Impact factor: 2.952

4.  Bimodal Fucoidan-Coated Zinc Oxide/Iron Oxide-Based Nanoparticles for the Imaging of Atherothrombosis.

Authors:  Hoang Nguyen; Eric Tinet; Thierry Chauveau; Frédéric Geinguenaud; Yoann Lalatonne; Aude Michel; Rachida Aid-Launais; Clément Journé; Caroline Lefèbvre; Teresa Simon-Yarza; Laurence Motte; Noureddine Jouini; Jean-Michel Tualle; Frédéric Chaubet
Journal:  Molecules       Date:  2019-03-08       Impact factor: 4.411

5.  Plasma P-selectin level is associated with severity of coronary heart disease in Chinese Han population.

Authors:  Chunhui Song; Guohai Wu; Sheng Chang; Lizhan Bie
Journal:  J Int Med Res       Date:  2020-06       Impact factor: 1.671

6.  Fucoidan-functionalized activated platelet-hitchhiking micelles simultaneously track tumor cells and remodel the immunosuppressive microenvironment for efficient metastatic cancer treatment.

Authors:  Rong Guo; Miao Deng; Xuan He; Mengmeng Li; Jiaxin Li; Penghui He; Houqin Liu; Man Li; Zhirong Zhang; Qin He
Journal:  Acta Pharm Sin B       Date:  2021-06-16       Impact factor: 11.413

Review 7.  Fucoidans: Downstream Processes and Recent Applications.

Authors:  Ahmed Zayed; Roland Ulber
Journal:  Mar Drugs       Date:  2020-03-18       Impact factor: 5.118

Review 8.  Endothelial cells, neutrophils and platelets: getting to the bottom of an inflammatory triangle.

Authors:  Tima Dehghani; Alyssa Panitch
Journal:  Open Biol       Date:  2020-10-14       Impact factor: 6.411

Review 9.  Nanoparticle-Based Technology Approaches to the Management of Neurological Disorders.

Authors:  Tao Ming Sim; Dinesh Tarini; S Thameem Dheen; Boon Huat Bay; Dinesh Kumar Srinivasan
Journal:  Int J Mol Sci       Date:  2020-08-23       Impact factor: 5.923

Review 10.  Current Strategies for Microbubble-Based Thrombus Targeting: Activation-Specific Epitopes and Small Molecular Ligands.

Authors:  Zhaojian Wang; Huaigu Huang; Yuexin Chen; Yuehong Zheng
Journal:  Front Bioeng Biotechnol       Date:  2021-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.